Article
Psoriasiform Drug Eruption Secondary to Sorafenib: Case Series and Review of the Literature
- Author:
- Courtney J. Ensslin, MD
- Pei-han Kao, MD
- Ming-ying Wu, MD
- Yao-yu Chang, MD
- Tseng-tong Kuo, MD, PhD
- Chia-hsun Hsieh, MD, MS
- Sen-yung Hsieh, MD, PhD
- Chih-Hsun Yang, MD
- Lloyd S. Miller, MD, PhD
The expanding use of novel targeted anticancer agents such as sorafenib has led to an increasing number of dermatologic adverse events. This...